• Citer

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

par Piccart-Gebhart, Martine ;Bertelsen, K;James, K;Cassidy, J;Mangioni, C;Simonsen, E;Stuart, G;Kaye, Steve;Vergote, Ignace;Blom, R;Grimshaw, R;Atkinson, R J;Swenerton, K D;Trope, C;Nardi, M;Kaern, J;Tumolo, Salvatore;Timmers, P;Roy, J A;Lhoas, F;Lindvall, B;Bacon, M;Birt, A;Andersen, Joern Erik;Zee, Benny;Paul, J;Baron, Benoît;Pecorelli, Sërgio
Référence Journal of the National Cancer Institute, 92, 9, page (699-708)
Publication Publié, 2000-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
Auteur:	Piccart-Gebhart, Martine; Bertelsen, K; James, K; Cassidy, J; Mangioni, C; Simonsen, E; Stuart, G; Kaye, Steve; Vergote, Ignace; Blom, R; Grimshaw, R; Atkinson, R J; Swenerton, K D; Trope, C; Nardi, M; Kaern, J; Tumolo, Salvatore; Timmers, P; Roy, J A; Lhoas, F; Lindvall, B; Bacon, M; Birt, A; Andersen, Joern Erik; Zee, Benny; Paul, J; Baron, Benoît; Pecorelli, Sërgio
Informations sur la publication:	Journal of the National Cancer Institute, 92, 9, page (699-708)
Statut de publication:	Publié, 2000-05
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Alopecia -- chemically induced
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Cisplatin -- administration & dosage
	Cisplatin -- adverse effects
	Combined Modality Therapy
	Cross-Over Studies
	Cyclophosphamide -- administration & dosage
	Cyclophosphamide -- adverse effects
	Disease Progression
	Female
	Follow-Up Studies
	Humans
	Middle Aged
	Nausea -- chemically induced
	Neoplasm Staging
	Neutropenia -- chemically induced
	Ovarian Neoplasms -- drug therapy
	Ovarian Neoplasms -- mortality
	Ovarian Neoplasms -- surgery
	Paclitaxel -- administration & dosage
	Paclitaxel -- adverse effects
	Survival Analysis
	Thrombocytopenia -- chemically induced
	Time Factors
	Treatment Outcome
	Vomiting -- chemically induced
Note générale:	Clinical Trial
	Clinical Trial, Phase III
	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0027-8874
	info:pmid/10793106